Business Daily from THE HINDU group of publications
Wednesday, May 14, 2008
ePaper | Mobile/PDA Version | Audio


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Awards & Honours
States - Andhra Pradesh
Natco Pharma gets national award

Hyderabad, May 13

Hyderabad-based Natco Pharma Ltd has been conferred with the national award for its indigenous development of life saving anti-cancer drugs. The Technology Development Board’s annual award 2008, for successful commercialisation of indigenous technology, given on the occasion of the Technology Day (May 11), was received by the company’s Chairman and Managing Director, Mr V.C. Nannapaneni, and Dr A.K.S. Bhujanga Rao, President (R&D), Dr A.K.S. Bhujanga Rao, i n New Delhi on Sunday. –

Our Bureau

More Stories on : Awards & Honours | Pharmaceuticals | Andhra Pradesh

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Merck deal: Fruits for Ranbaxy R&D arm


Ford India to double diesel engine output
Piramal’s diabetic drug enters clinical trials
BEML gets Rs 777-cr SAIL contract
PSL arm bags Japanese order
Natco Pharma gets national award
Varun Shipping makes Rs 62-cr provision for forex loss
Deora seeks more oil bonds to cover firms’ losses
Gujarat Paguthan gets Rs 445-cr ADB loan for wind energy projects
Honda to start production of engine parts in September
‘Withdraw export duty on steel products to finishing units’
Star Panel Boards to invest Rs 900 cr for expansion
Tata, Israel Aerospace agree to make defence products
Sanjay Ghodawat to invest Rs 100 cr for wind turbine facility near Kolhapur
Hero Electric to work on making batteries cheaper
L.G. Ramamurthi passes away
K.K. Swamy quits Toyota Kirloskar; may join VW


Smartbuy



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line